DENYES NANCY

ATYR

DENYES NANCY serves as officer: General Counsel at aTyr Pharma, Inc. (ATYR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$9.3K

Total Sells

3 trades

$5.6K

Net Position

Net Buyer

$3.7K

Companies Traded

ATYR

Active Period

Jun 2024 – Feb 2026

4 total trades

Most Recent

Sell ATYR

Feb 4, 2026 · $1.1K

DENYES NANCY's Insider Trading at aTyr Pharma, Inc. (ATYR)

Buys

1 · $9.3K

Sells

3 · $5.6K

Total Shares Bought

5,000

Total Shares Sold

3,135

ATYR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 4, 2026	Sell	1,118	$0.98	$1.1K	33,124
Feb 3, 2026	Sell	1,118	$0.98	$1.1K	0
Feb 3, 2025	Sell	899	$3.78	$3.4K	0
Jun 5, 2024	Buy	5,000	$1.86	$9.3K	0

Related Insiders

Jill Marie Broadfoot

officer: Chief Financial Officer

ATYRSell · Feb 4, 2026

Sanjay Shukla

President and CEO

ATYRSell · Feb 4, 2026

SCHIMMEL PAUL

Director

ATYRBuy · Oct 8, 2025

Explore More Insider Trading Data

ATYR Insider Trading Activity

View all insider trades at aTyr Pharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity